Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.

[1]  J. F. Wolfe,et al.  Antinuclear antibody with distinct specificity for polymyositis. , 1977, The Journal of clinical investigation.

[2]  J. F. Wolfe,et al.  Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen. , 1984, The Journal of rheumatology.

[3]  M. Reichlin,et al.  Nucleolar localization of the PM-Scl antigen. , 1985, Arthritis and rheumatism.

[4]  G. Reimer,et al.  Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. , 1986, Journal of immunology.

[5]  J. Rodríguez-Sánchez,et al.  Identification of protein components reactive with anti‐PM/Scl autoantibodies , 1990, Clinical and experimental immunology.

[6]  M. Meurer,et al.  Immunogenetic associations of scleroderma-related antinuclear antibodies. , 1990, Arthritis and rheumatism.

[7]  E. Chan,et al.  Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: a unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex , 1991, The Journal of experimental medicine.

[8]  M. Blüthner,et al.  Cloning and characterization of the cDNA coding for a polymyositis- scleroderma overlap syndrome-related nucleolar 100-kD protein , 1992, The Journal of experimental medicine.

[9]  M. Walport,et al.  The Clinical and Immunogenetic Features of Patients with Autoantibodies to the Nucleolar Antigen PM-Scl , 1992, Medicine.

[10]  I. Targoff,et al.  Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen. , 1992, The Journal of clinical investigation.

[11]  M. Trucco,et al.  Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations. , 1992, Arthritis and rheumatism.

[12]  M. Kuwana,et al.  Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. , 1994, Arthritis and rheumatism.

[13]  E. Tan,et al.  Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .

[14]  E. Tan,et al.  Autoantibodies in the diagnosis of systemic rheumatic diseases. , 1995, Seminars in arthritis and rheumatism.

[15]  I. Hausmanowa-Petrusewicz,et al.  Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. , 1997, Arthritis and rheumatism.

[16]  I. Hausmanowa-Petrusewicz,et al.  Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. , 1997 .

[17]  O. Beyne-Rauzy,et al.  Acquired haemophilia and PM-Scl antibodies. , 2000, Rheumatology.

[18]  M. Mahler,et al.  Identification of an α-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25β autoantigen using immobilized overlapping synthetic peptides , 2000, Journal of Molecular Medicine.

[19]  D. Isenberg,et al.  Autoantibody profiles in the sera of European patients with myositis , 2001, Annals of the rheumatic diseases.

[20]  H. Eenennaam,et al.  Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations , 2002, Clinical and experimental immunology.

[21]  D. Generali,et al.  Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients. , 2002, The Journal of rheumatology.

[22]  G. Pruijn,et al.  Autoantibodies directed to novel components of the PM/Scl complex, the human exosome , 2001, Arthritis research.

[23]  M. Mahler,et al.  Advances in B-cell epitope analysis of autoantigens in connective tissue diseases. , 2003, Clinical immunology.

[24]  G. Pruijn,et al.  The Association of the Human PM/Scl-75 Autoantigen with the Exosome Is Dependent on a Newly Identified N Terminus* , 2003, Journal of Biological Chemistry.

[25]  J. Reveille,et al.  The clinical relevance of autoantibodies in scleroderma , 2003, Arthritis research & therapy.

[26]  R Hal Scofield,et al.  Development of autoantibodies before the clinical onset of systemic lupus erythematosus. , 2003, The New England journal of medicine.

[27]  S. Jabłońska,et al.  Scleromyositis (scleroderma/polimyositis overlap) is an entity , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  E. Greidinger,et al.  Patients with antibodies to both PmScl and dsDNA. , 2004, The Journal of rheumatology.

[29]  T. Bunch,et al.  Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes , 2004, Journal of Clinical Immunology.

[30]  G. Pruijn,et al.  PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome. , 2004, Arthritis and rheumatism.

[31]  R. Raijmakers,et al.  Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen , 2005, Arthritis research & therapy.

[32]  H. Chapel,et al.  Dysphagia associated with anti‐PM‐Scl antibodies in systemic lupus erythematosus , 2006, Scandinavian journal of rheumatology.

[33]  A. Selva-O'Callaghan,et al.  Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy. , 2006, Arthritis and rheumatism.

[34]  G. Pruijn,et al.  Cell and molecular biology of the exosome: how to make or break an RNA. , 2006, International review of cytology.

[35]  A. Silman,et al.  In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype , 2005, Arthritis research & therapy.

[36]  J. Sibilia,et al.  Anti-pm/scl antibodies in connective tissue disease: Clinical and biological assessment of 14 patients. , 2006, Clinical and experimental rheumatology.

[37]  M. Carrington,et al.  Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies , 2006, Medicine.